Natco Total Current Assets from 2010 to 2024

NATCOPHARM   1,376  38.05  2.84%   
Natco Pharma's Total Current Assets are increasing with slightly volatile movements from year to year. Total Current Assets are estimated to finish at about 42.2 B this year. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2012-03-31
Previous Quarter
18.5 B
Current Value
50 B
Quarterly Volatility
11.6 B
 
Yuan Drop
 
Covid
Check Natco Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Natco Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 B, Interest Expense of 180 M or Total Revenue of 42 B, as well as many indicators such as . Natco financial statements analysis is a perfect complement when working with Natco Pharma Valuation or Volatility modules.
  
This module can also supplement various Natco Pharma Technical models . Check out the analysis of Natco Pharma Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Natco Stock

Natco Pharma financial ratios help investors to determine whether Natco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natco with respect to the benefits of owning Natco Pharma security.